期刊文献+

星点设计-效应面法优化知母盐制的炮制工艺 被引量:5

Optimization of the Rhizoma Anemarrhenae of salt with central composite design and reponse surface methodology
下载PDF
导出
摘要 目的采用星点设计-效应面法以进一步优化盐制知母的炮制工艺,保证临床疗效。方法以具有降血糖作用的活性成分知母皂苷B-Ⅲ、知母皂苷A-Ⅲ、芒果苷的总含量为指标。以加盐量、炒炙时间、炒炙温度为考察因素,采用星点设计-效应面法(CCD)优选炮制条件,并进行预测分析。结果最优炮制工艺为加盐量3g,炒炙12min,炒炙温度为150℃。结论本次实验使用盐制知母,并采用星点设计-效应面法优化知母的盐炙工艺,并且预测性良好。 Objective To optimize the processing technology of Rhizoma Anemarrhenae of salt by central composite design and response surface methodology. Methods The total contents of saponins B-Ⅲ,A-Ⅲ and mangiferin of Anemarrhenoside B-Ⅲ and mangiferin with hypoglycemic effect were taken as indexes.The amount of salt added,the time of frying and the temperature of frying were taken as the investigation factors,the central Composite Design and reponse Surface Methodology was used to optimize the processing conditions of central composite design CCDs,and the prediction and analysis were carried out. Results The optimum processing technology was 3 g of salt,12 min of frying and 150 ℃ of temperature. Conclusion In this experiment,salt was used to make Anemarrhena,and Central composite design and response surface methodology was used to optimize the salt-burning process of Anemarrhena anemarrhenae with good predictability.
出处 《中国医药科学》 2018年第3期42-46,50,共6页 China Medicine And Pharmacy
基金 国家自然科学基金(81102810) 辽宁省自然科学基金项目(2013020165)
关键词 知母 效应面法 炮制 知母皂苷BⅢ 知母皂苷AⅢ 芒果苷 Anemarrhena Effect surface method Processing Anemarrhenoside B-Ⅲ Anemarrhenoside A-Ⅲ Mangiferin
  • 相关文献

参考文献16

二级参考文献139

  • 1刘晓强,钟日辉,严海燕.404株大肠埃希菌耐药性变迁分析[J].实用医技杂志,2008,15(32):4531-4533. 被引量:5
  • 2卓超,苏丹虹,倪语星,孙景勇,俞云松,杨青,孙自镛,简翠,汪复,朱德妹,胡付品,蒋晓飞,王传清,王爱敏,徐元宏,沈继录,徐英春,孙宏莉,张泓,李万华,单斌,杜艳,张朝霞,季萍,贾蓓,黄文祥,魏莲花,吴玲,胡云建,艾效曼.2009年中国CHINET大肠埃希菌和克雷伯菌属细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):430-435. 被引量:81
  • 3俞云松.超广谱β-内酰胺酶研究进展[J].中华医学杂志,2006,86(9):641-644. 被引量:95
  • 4雷延昌,张正茂,丁红晖,杨东亮,孙自镛,申正义.耐亚胺培南铜绿假单胞菌的耐药性与金属β-内酰胺酶的关系[J].中华医院感染学杂志,2007,17(4):370-374. 被引量:21
  • 5Gupta K, Hooton T M,Stamm W E. Increasing antimicrobial resistance and the management of uncomplicated community--acquired urinary tract infections[J]. Ann Intern Meal,2001,135(1):41--50.
  • 6Warren J W, Abrutyn E, Hebel J R , et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women[J]. Clin Infect Dis, 1999,29 : 745-- 758.
  • 7Lindsay N, Peter A M, Anderson J C, et al. Uncomplicated urinary tract infection in women current practice and the effect of antibiotic resistance on empiric treatment[J]. Can Fam Physician, 2006, 52 (5) : 612--618.
  • 8Wagenlehner F M, Weidner W, Naber K G. An update on uncomplicared urinary tract infections in women[J]. Curr Opin Urol, 2009, 19(4) : 368-374.
  • 9Guay D R. Contemporary management of uncomplicated urinary tract infections[J]. Drugs, 2008,68 (9) : 1169 -- 1205.
  • 10SA Mehnert--Kay. Diagnosis and management of uncomplicated urinary tract infections [J]. Am Fam Physician, 2005,72 (3) : 451 -- 456.

共引文献361

同被引文献60

引证文献5

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部